Picture of GlobeImmune logo

GBIM — GlobeImmune News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Brief: GlobeImmune Celgene Corporation entered into Celgene amendment' agreement

Aug 4 (Reuters) - GlobeImmune Inc  GBIM.O : 
 * Says on July 31, 2015 co and Celgene Corporation entered into Celgene 
   amendment' agreement 
 * Says Celgene amendment provides company's gi-6100 program replaced the 
   company's gi-3000 program as a drug candidate 
 * Globeimmune -co eligible for milestone payments of up to $145 mln,and tiered 
   royalty payments in the low teens for sales of gi-6100 
 
* Source text for Eikon  ID:nEOL9G7tff  
 
* Further company coverage  GBIM.O  ((Bengaluru Newsroom; +1 646 223 8780))

Recent news on GlobeImmune

See all news